Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Company History
Acquisitions
Partnerships
Leadership Team
Board of Directors
Research & Development Team
Medical, Scientific and Technology Advisory Board
Our Approach
IP & Drug Development
Clinical Trials
Technology
Drug Supply
Investigational Drug Supply
Special Access Program
News & Media
Blog
Press Releases
In The News
Investors
Overview
News & Events
Company Info
Financial Results
Stock Data
SEDAR
Governance
FAQs
Contact
Careers
Search
Financial Results
Investors
Investors
Overview
News & Events
Press Releases
Events
Email Alerts
Company Info
Overview
Leadership Team
Presentations
Contacts
FAQs
Financial Results
Stock Data
NEO: MYCO
OTCPINK: MYCOF
FSE: 0NFA
SEDAR
Governance
Board of Directors
FAQs
2021
FY 2021
Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF
HTML
Q3 2021
Quarter Ended Sep 30, 2021
Earnings Release
PDF
HTML
Q2 2021
Quarter Ended Jun 30, 2021
Earnings Release
PDF
HTML
Q1 2021
Quarter Ended Mar 31, 2021
Earnings Release
PDF
HTML
2020
FY 2020
Fiscal Year Ended Dec 31, 2020
Earnings Release
PDF
HTML
Audio
Earnings Webcast
Email Alerts
Contacts
RSS News Feed